246 related articles for article (PubMed ID: 8324150)
21. In vitro activity of ceftriaxone combined with tazobactam against anaerobic bacteria.
Wüst J; Hardegger U
Eur J Clin Microbiol Infect Dis; 1994 Feb; 13(2):177-81. PubMed ID: 8013494
[TBL] [Abstract][Full Text] [Related]
22. Comparative susceptibility profile of piperacillin/tazobactam against anaerobic bacteria.
Appelbaum PC
J Antimicrob Chemother; 1993 Jan; 31 Suppl A():29-38. PubMed ID: 8383654
[TBL] [Abstract][Full Text] [Related]
23. A five-year multicenter study of the susceptibility of the Bacteroides fragilis group isolates to cephalosporins, cephamins, penicillins, clindamycin, and metronidazole in the United States.
Aldridge KE; Gelfand M; Reller LB; Ayers LW; Pierson CL; Schoenknecht F; Tilton RC; Wilkins J; Henderberg A; Schiro DD
Diagn Microbiol Infect Dis; 1994 Apr; 18(4):235-41. PubMed ID: 7924220
[TBL] [Abstract][Full Text] [Related]
24. Patterns of resistance to anaerobic organisms in Australia.
Munro R
Diagn Microbiol Infect Dis; 1989; 12(4 Suppl):159S-163S. PubMed ID: 2591175
[TBL] [Abstract][Full Text] [Related]
25. [Detection of beta-lactamases in the Bacteroides fragilis group].
Martin C; Dubreuil L; Sedallian A; Romond C
Pathol Biol (Paris); 1990 May; 38(5):470-3. PubMed ID: 2367153
[TBL] [Abstract][Full Text] [Related]
26. The antimicrobial susceptibility patterns of the Bacteroides fragilis group in the United States, 1987.
Cornick NA; Cuchural GJ; Snydman DR; Jacobus NV; Iannini P; Hill G; Cleary T; O'Keefe JP; Pierson C; Finegold SM
J Antimicrob Chemother; 1990 Jun; 25(6):1011-9. PubMed ID: 2370237
[TBL] [Abstract][Full Text] [Related]
27. In vitro activity of cefoperazone/sulbactam and other antimicrobials against anaerobic bacteria.
D'Amato RF; Hochstein L; Frankel H
Diagn Microbiol Infect Dis; 1990; 13(1):51-5. PubMed ID: 2331850
[TBL] [Abstract][Full Text] [Related]
28. Susceptibility of anaerobic bacteria to Sch 34343 and other beta-lactam antibiotics.
Jacobus NV; Tally FP; Gorbach SL
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():189-91. PubMed ID: 4030547
[TBL] [Abstract][Full Text] [Related]
29. Bacteremia due to Bacteroides fragilis group: distribution of species, beta-lactamase production, and antimicrobial susceptibility patterns.
Aldridge KE; Ashcraft D; O'Brien M; Sanders CV
Antimicrob Agents Chemother; 2003 Jan; 47(1):148-53. PubMed ID: 12499183
[TBL] [Abstract][Full Text] [Related]
30. Effect of beta-lactamase inhibitors on the activities of various beta-lactam agents against anaerobic bacteria.
Wexler HM; Molitoris E; Finegold SM
Antimicrob Agents Chemother; 1991 Jun; 35(6):1219-24. PubMed ID: 1929265
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the inoculum effect of cefoxitin and other cephalosporins and of beta-lactamase inhibitors and their penicillin-derived components on the Bacteroides fragilis group.
Goldstein EJ; Citron DM; Cherubin CE
Antimicrob Agents Chemother; 1991 Sep; 35(9):1868-74. PubMed ID: 1952860
[TBL] [Abstract][Full Text] [Related]
32. Survey of the susceptibility patterns of Bacteroides fragilis group strains in France from 1977 to 1992.
Dubreuil L; Breuil J; Dublanchet A; Sedallian A
Eur J Clin Microbiol Infect Dis; 1992 Nov; 11(11):1094-9. PubMed ID: 1295764
[TBL] [Abstract][Full Text] [Related]
33. [ESBL-positive strains of the Bacteroides fragilis group isolated from patients at the regional hospital center in Płock (Poland)].
Rokosz A; Pawłowska J; Sawicka-Grzelak A; Luczak M
Med Dosw Mikrobiol; 2004; 56(3):245-53. PubMed ID: 15773501
[TBL] [Abstract][Full Text] [Related]
34. Antimicrobial susceptibility of anaerobic bacteria in Australia.
Chen SC; Gottlieb T; Palmer JM; Morris G; Gilbert GL
J Antimicrob Chemother; 1992 Dec; 30(6):811-20. PubMed ID: 1289355
[TBL] [Abstract][Full Text] [Related]
35. An in-vitro and in-vivo comparison of the activity of beta-lactamase inhibitor combinations with imipenem and cephalosporins against Escherichia coli producing TEM-1 or TEM-2 beta-lactamase.
Cherubin CE; Eng RH; Smith SM; Tan EN
J Antimicrob Chemother; 1991 Jul; 28(1):61-70. PubMed ID: 1769944
[TBL] [Abstract][Full Text] [Related]
36. Multicenter study of in vitro susceptibility of the Bacteroides fragilis group, 1995 to 1996, with comparison of resistance trends from 1990 to 1996.
Snydman DR; Jacobus NV; McDermott LA; Supran S; Cuchural GJ; Finegold S; Harrell L; Hecht DW; Iannini P; Jenkins S; Pierson C; Rihs J; Gorbach SL
Antimicrob Agents Chemother; 1999 Oct; 43(10):2417-22. PubMed ID: 10508018
[TBL] [Abstract][Full Text] [Related]
37. Resistance to beta-lactam antibiotics in anaerobic bacteria.
Nord CE; Hedberg M
Rev Infect Dis; 1990; 12 Suppl 2():S231-4. PubMed ID: 2406875
[TBL] [Abstract][Full Text] [Related]
38. [Comparative in vitro activity of ampicillin, cefoperazone and their combinations with sulbactam, as well as that of other antibiotics against anaerobic organisms].
Rezvan SP; Sidorenko SV; Budanov SV
Antibiot Khimioter; 1995 Apr; 40(4):25-9. PubMed ID: 7654095
[TBL] [Abstract][Full Text] [Related]
39. Implications of beta-lactamase-inhibitor combinations.
Fuchs PC; Barry AL
J Reprod Med; 1990 Mar; 35(3 Suppl):317-21. PubMed ID: 2319514
[TBL] [Abstract][Full Text] [Related]
40. Emerging resistance of anaerobic bacteria to antimicrobial agents in South Korea.
Lee K; Chong Y; Jeong SH; Xu XS; Kwon OH
Clin Infect Dis; 1996 Dec; 23 Suppl 1():S73-7. PubMed ID: 8953110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]